April 19, 2010 (Monday)
Neurodegeneration (Alzheimer's, Parkinson's Disease and Aging)
This session will provide a practical introduction to how clinical trials are designed, staged (Phase 1-3, etc.) and conducted.
Describe the purpose of randomization and the use of "double-blind controls".
What's the advantage of a cross-over trial design?
Describe some of the factors in selecting the best "outcome variable" for a clinical trial.
Marshall FJ, Kieburtz K, McDermott M, et al (1996) Clinical research in neurology. From observation to experimentation. Neurol Clin 14:451-466.
Last modified on 06/02/2010 by